Russell Investments Group
NRC icon

Russell Investments Group’s NRC Health Common Stock NRC Stock Holding History

Russell Investments Group’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.1K Buy
4,087
+2,359
+137% +$43.8K ﹤0.01% 3482
2026
Q1 		$29.4K Sell
1,728
-480
-22% -$8.16K ﹤0.01% 3498
2025
Q4 		$41.4K Buy
2,208
+211
+11% +$3.19K ﹤0.01% 3369
2025
Q3 		$25.5K Buy
1,997
+921
+86% +$13.8K ﹤0.01% 3523
2025
Q2 		$18.1K Buy
1,076
+276
+35% +$3.73K ﹤0.01% 3219
2025
Q1 		$10.2K Sell
800
-180
-18% -$2.89K ﹤0.01% 3232
2024
Q4 		$17.3K Buy
980
+645
+193% +$12.2K ﹤0.01% 3036
2024
Q3 		$7.66K Sell
335
-14,009
-98% -$317K ﹤0.01% 3147
2024
Q2 		$329K Sell
14,344
-4
-0% -$123 ﹤0.01% 2346
2024
Q1 		$568K Buy
14,348
+847
+6% +$33.5K ﹤0.01% 2165
2023
Q4 		$534K Buy
13,501
+70
+0.5% +$2.93K ﹤0.01% 2189
2023
Q3 		$596K Buy
13,431
+152
+1% +$6.63K ﹤0.01% 2161
2023
Q2 		$578K Hold
13,279
– – ﹤0.01% 2173
2023
Q1 		$578K Buy
+13,279
New +$586K ﹤0.01% 2200
2020
Q4 		– Sell
-1,457
Closed -$71K – 3145
2020
Q3 		$71K Hold
1,457
– – ﹤0.01% 3037
2020
Q2 		$84K Sell
1,457
-241
-14% -$12.7K ﹤0.01% 2918
2020
Q1 		$77K Buy
+1,698
New +$102K ﹤0.01% 2800
2019
Q1 		– Sell
-2,237
Closed -$85K – 2977
2018
Q4 		$85K Sell
2,237
-9,736
-81% -$374K ﹤0.01% 2744
2018
Q3 		$462K Hold
11,973
– – ﹤0.01% 2421
2018
Q2 		$448K Buy
11,973
+2,237
+23% +$77.9K ﹤0.01% 2427
2018
Q1 		$285K Buy
9,736
+918
+10% +$30.8K ﹤0.01% 2607
2017
Q4 		$330K Sell
8,818
-201
-2% -$7.14K ﹤0.01% 2557
2017
Q3 		$340K Hold
9,019
– – ﹤0.01% 2560
2017
Q2 		$243K Sell
9,019
-5,669
-39% -$139K ﹤0.01% 2642
2017
Q1 		$289K Hold
14,688
– – ﹤0.01% 2612
2016
Q4 		$276K Buy
+14,688
New +$242K ﹤0.01% 2643

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
FMII
Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Russell Investments Group's NRC Position: Q2 2026 in Review

Russell Investments Group increased its NRC Health Common Stock (NRC) stake by 137% in Q2 2026, buying an estimated $43.8K and bringing the position to 4,087 shares worth $88.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3482.

Russell Investments Group first reported a position in NRC in Q4 2016 and has held it in 26 quarters since. The position peaked at $596K in Q3 2023. 124 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

  • Russell Investments Group held 4,087 shares of NRC Health Common Stock worth $88.1K as of Q2 2026.
  • Russell Investments Group bought 2,359 NRC Health Common Stock shares in Q2 2026, an estimated $43.8K.
  • NRC Health Common Stock made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3482 holding.
  • Russell Investments Group first reported a position in NRC Health Common Stock in Q4 2016 and has held it in 26 quarters since.
  • Russell Investments Group's NRC Health Common Stock position peaked at $596K in Q3 2023.
  • 124 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.